SUBSCRIBE: Apple Podcasts | Spotify
In this episode, Dr. Morgentaler discusses flawed research linking testosterone therapy to heart risk, explains why cardiovascular safety is largely settled, clarifies stress and lifestyle effects on testosterone, addresses lifelong treatment myths, and examines the evolving FDA stance on testosterone therapy.
- 03:08 – Analyzing the Controversial Study: Dr. Morgentaler breaks down a 2026 paper claiming heart risks with testosterone and explains the major flaws that make its conclusions unreliable.
- 21:29 – Impact of Stress on Testosterone: He explains how emotional and physical stress suppress brain signaling, lowering testosterone and overall hormonal balance.
- 26:14 – Natural Testosterone Recovery and Long-Term Use: Dr. Morgentaler clarifies whether starting testosterone means lifelong dependence and who may naturally recover production.
- 26:34 – Diet, Exercise, and Supplements for Testosterone Boost: He reviews what actually works (and what doesn’t) when it comes to lifestyle, diet, and supplements for raising testosterone.
- 34:51 – FDA Panel on Testosterone: Insights and Experiences: He shares his experience speaking at the FDA panel and discusses shifting regulatory attitudes toward testosterone therapy.
Resources
Bal et al.; Patel (2026). Dissociation Between Testosterone Replacement Therapy and Cardiovascular Events in Men. Journal of Sexual Medicine.
Vigen et al. (2013). Association of Testosterone Therapy With Mortality, MI, and Stroke. JAMA.
Zhao et al. (Referenced cardiovascular risk study cited in discussion.)
TRAVERSE Trial (2023). Cardiovascular Safety of Testosterone Therapy. New England Journal of Medicine.
Morgentaler & Crawford et al. Study on diurnal variation in testosterone levels (time-of-day testing data).
